Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
Blueprint Medicines Corporation - Common Stock   (ticker: BPMC)
Quote:() Quotes on: Yahoo | Google
5 day's Perf: 100%
1 Month Perf: 100%
3 Month Perf: 100%
YTD Perf: 100%
1 Year Perf: 100%
Stock chart
Useful Quick Links for BPMC
Financial Key Date: Yahoo
Option Prices: MarketWatch
Technical Opinion: Barchar.com
Technical Charts: StockCharts.com
Analyst & Estimates: Reuters
Ratings: TheStreet.com
SEC Filings: EDGAR Online
Message Boards: Yahoo | TheLion
Insiders' Indicator :          Sell          (Click Here For Details)
INSIDERS' Score: 30
0 100 30
Latest 1 month: 0 52,949
Latest 6 Months: 0 89,688
52 Weeks: 0 170,871
Gurus' Indicator :          Hold          (Click Here For Details)
GURUS' Score: 50
0 100 50
Current Holdings: 0
Previous Holdings: 0
Change: 0
Institutions' Indicator :          Hold          (Click Here For Details)
0 100 50
Current Holdings: 0
Previous Holdings: 0
Change: 0
News And Links For The Group (Contribute a link)
[BPMC]   Blueprint Medicines Announces Publication in The Lancet Oncology Showing Durable Clinical Benefits of AYVAKIT? (avapritinib) in NAVIGATOR Trial Patients with PDGFRA D842V Mutant GIST  (PR Newswire)   29-Jun-20 18:30
[BPMC]   Blueprint Medicines Presents Updated Part 1 Data from PIONEER Trial of Avapritinib Showing Robust Reductions in Cutaneous Disease Symptoms in Patients with Indolent Systemic Mastocytosis  (PR Newswire)   6-Jun-20 09:00
[BPMC]   CytomX Slumps On Data, And Other News: The Good, Bad And Ugly Of Biopharma  (Seeking Alpha)   18-May-20 11:04
[BPMC]   Week In Review: Akeso Stages $335 Million HK IPO For Mono-/Bi-Specific Antibodies  (Seeking Alpha)   26-Apr-20 09:42
[BPMC]   Deciphera Pharmaceuticals: Updates To Thesis, Expecting A Rebound Ahead Of August PDUFA  (Seeking Alpha)   13-Apr-20 04:23
[BPMC]   Blueprint's Avapritinib Shows Promise For Indolent Systemic Mastocytosis  (Seeking Alpha)   2-Apr-20 18:37
[BPMC]   Week In Review: Abbisko Raises $70 Million To Develop Cancer Drug Candidates  (Seeking Alpha)   30-Mar-20 05:12
[BPMC]   Blueprint Hits Study Goal With Main Drug Avapritinib, Additional Studies Being Advanced  (Seeking Alpha)   24-Mar-20 11:08
[BPMC]   Blueprint Medicines Corporation: An Undervalued Company With Attractive Prospects  (Seeking Alpha)   20-Mar-20 15:11
[BPMC]   Blueprint Medicine's Most Recent Raise Is A Necessary Desperation  (Seeking Alpha)   7-Feb-20 10:41
[BPMC]   Blueprint Secures Favorable FDA Approval For PDGFRA Exon 18 Mutant GIST  (Seeking Alpha)   17-Jan-20 03:36
[BPMC]   Week In Review: 4 China Biopharmas Announce $100+ Million Deals In First Week Of 2020  (Seeking Alpha)   12-Jan-20 11:22
[BPMC]   Blueprint Medicines: GIST Setback Unlikely To Deter Future  (Seeking Alpha)   12-Nov-19 12:44
[BPMC]   Blueprint Medicines A Buy: Genome Biotech Development  (Seeking Alpha)   2-Nov-19 10:29
[BPMC]   Eli Lilly Throws Hat In The Ring For Lung Cancer Space, Takes Targeted Treatment Approach  (Seeking Alpha)   25-Sep-19 15:21
[BPMC]   Deciphera Pharmaceuticals: Updates To Thesis, Further Upside Ahead Post Phase 3 Win  (Seeking Alpha)   20-Aug-19 17:25
[BPMC]   Blueprint Medicines Appears Increasingly Competitive In RET-Mutated NSCLC  (Seeking Alpha)   29-Jul-19 10:35
[BPMC]   Biotechs' Second-Half Battle  (Seeking Alpha)   22-Jul-19 12:32
[BPMC]   Blueprint Medicines: Conviction In Precision Oncology  (Seeking Alpha)   22-Jul-19 11:52
[BPMC]   All Eyes On Biotech M&A  (Seeking Alpha)   13-Jul-19 07:30
==>More News
*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*